Caixa joins CRB in €3m round for Nuubo
Caixa Capital Risc and CRB Inverbio have committed €3m to wearable medical technology company Nuubo.
Caixa invested via Caixa Innvierte BioMed II, which launched in March 2014 with a €35m target. CRB committed capital from CRB Bio II.
Fides Capital, an existing backer, remains the lead investor in the company alongside new minority partners.
The company expects to grow its revenues in Europe with the aim of exceeding €1m of sales in 2014.
Company
Founded in 2012 and based in Madrid, Nuubo has developed biomedical garments for heart monitoring. The firm's technology allows the electrocardiogram to be read continuously in a non-invasive manner via a piece of clothing. Data can be sent wirelessly and in real time. The firm has also developed analysis and visualisation using artificial intelligence algorithms.
Nuubo employs 22 staff.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








